(secondQuint)Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection.

.

 The objective of this study is to provide adefovir dipivoxil 10 mg once daily to patients with chronic hepatitis B virus(HBV) infection who have completed a Gilead-sponsored study of adefovir dipivoxil and require continued access to adefovir dipivoxil.

 The secondary objective of this study is to evaluate the safety of chronic therapy with adefovir dipivoxil 10 mg.

.

 Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection.

@highlight

Provide adefovir dipivoxil (Hepsera) 10 mg once daily to patients with chronic hepatitis B virus (HBV) infection who have completed a Gilead-sponsored study of adefovir dipivoxil and require continued access to adefovir dipivoxil.

